La Caixa, Suanfarma Biotech and Milar Ventures invest 1.6 million euros in Pevesa Biotech

by Suanfarma Biotech SGECR

"La Caixa", through the specialized in industrial technologies Fund, Caixa Innvierte Industria, and current members of Pevesa Biotech, SuanFarma Biotech and Milar Ventures, announced an investment of ...

Read more

St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

by Ysios Capital

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced results of the TOCCASTAR clinical trial at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions...

Read more

The Carlyle Group Closes Carlyle Sub-Saharan Africa Fund at almost $700 million

by The Carlyle Group

Global alternative asset manager The Carlyle Group (NASDAQ: CG) today announced the final close of Carlyle Sub-Saharan Africa Fund (CSSAF), reaching $698 million, almost $200 million above its initial...

Read more

Kala Pharmaceuticals Announces $22.5 Million Series B Financing

by Ysios Capital

Kala Pharmaceuticals Announces $22.5 Million Series B Financing

Read more

Inveready entra en el capital de Ojer Pharma

by Professional Newco

Ojer Pharma ha cerrado una nueva ronda de financiación liderada por Inveready Innvierte Biotech II. La farmacéutica creada en 2005, spin-off de la Universidad de Navarra, desarrolla medicamentos de ...

Read more

3P Biopharmaceuticals increases its capital by 6M€

by Professional Newco

The Navarrese company 3P Biopharmaceuticals has announced today a capital increase of 6 million euros. The operation was carried out through the share ownership of a new partner, the Spanish pharmaceu...

Read more

AM-Pharma closes €12.2m financing round

by Ysios Capital

​AM‐Pharma B.V., a biopharmaceutical company focused on the development of recAP (recombinant human Alkaline Phosphatase) for inflammatory indications, announces that it has closed a €12.2 milli...

Read more

Nanogap: nanopartículas 'made in Spain' a la conquista del mundo

by Expansión
  • 10 years ago

Esta prometedora 'start up' gallega, fundada en 2006 como una spin-off de la Universidad de Santiago de Compostela, acaba de cerrar una nueva ronda de financiación de 2,2 millones de euros, liderada ...

Read more

Ysios cerrará este año un fondo con 100 millones para bioempresas

by CincoDías
  • 10 years ago

La firma de capital riesgo en la que participa Cristina Garmendia espera concluir la captación con socios institucionales y privados

Read more

Los inversores de Silicon Valley viran de las 'apps' a la ciencia

by TICbeat
  • 10 years ago

Parece que los intereses de las firmas de capital riesgo se centran en las empresas emergentes enfocadas en la ciencia, ingeniería o las tecnologías limpias.

Read more

CAF, nuevo inversor en el Fondo de capital riesgo CRB Bio II, con una aportación de 3,9 millones

by CRB Inverbío SA SGECR

CAF compromete el 11,5% de las participaciones en el total de capital gestionado por el fondo, que ya ha invertido en siete compañías de diagnóstico de enfermedades neurodegenerativas y cardiovascu...

Read more

InKemia adquiere el 9% del capital de LeanBio

by Professional Newco

El Fondo de Capital Conocimiento de InKemia entra en el accionariado de la compañía especializada en la industrialización de procesos Biotecnológicos a través de una Ampliación de Capital

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Latest transactions in the Data Analytic...

by Baker Tilly

There have been a number of strategic acquisitions of companies in the...

Photos Stream